Patent classifications
C
C12
C12N
2750/00
C12N2750/00011
C12N2750/14011
C12N2750/14211
C12N2750/14251
C12N2750/14251
ERYTHROPARVOVIRUS WITH A MODIFIED CAPSID FOR GENE THERAPY
Disclosed are recombinant virions that have a modified capsid protein or a variant thereof of erythroparvovirus and a nucleic acid that includes a heterologous nucleic acid.
ERYTHROPARVOVIRUS COMPOSITIONS AND METHODS FOR GENE THERAPY
Disclosed are recombinant virions that have a capsid protein or a variant thereof of erythroparvovirus and a nucleic acid that includes a heterologous nucleic acid.